D35.2
Benign neoplasm of pituitary gland
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign neoplasm of the pituitary gland, also known as a pituitary adenoma, is a non-cancerous tumor that develops in the pituitary gland, a small pea-shaped gland located at the base of the brain. This gland plays a crucial role in producing hormones that regulate various bodily functions, including growth, metabolism, and reproductive processes. While these tumors are typically benign and do not spread to other parts of the body, they can impact the normal functioning of the pituitary gland, leading to various health issues.
Causes & Symptoms
Clinical Causes: Genetic factors that influence cell growth and division in the pituitary gland Hormonal imbalances that may promote tumor development Family history of endocrine tumors or pituitary adenomas Multiple endocrine neoplasia (MEN) syndromes Radiation exposure to the head or brain Previous pituitary or brain surgery or injury
Key Symptoms: Headaches, often persistent and severe Visual disturbances, such as blurred vision or loss of peripheral vision Hormonal symptoms depending on tumor activity: Prolactinoma symptoms: irregular or absent menstrual periods, erectile dysfunction, and inappropriate breast milk production Growth hormone-secreting tumors: excessive growth of hands and feet, enlarged facial features (acromegaly) ACTH-secreting tumors: signs of Cushing's syndrome, such as weight gain, especially around the abdomen and face, purple stretch marks, and high blood pressure Hypopituitarism symptoms: fatigue, weakness, mood changes, decreased libido, and abnormal growth Nausea and vomiting if the tumor causes increased intracranial pressure
Diagnostic & Treatment
Diagnosis Path: Diagnosing a benign pituitary neoplasm involves a combination of clinical evaluation and diagnostic tests, including: - Blood tests to measure hormone levels and assess gland function - Magnetic resonance imaging (MRI) of the brain to visualize the size and location of the tumor - Visual field assessment to detect any visual impairments caused by the tumor pressing on optic nerves - Sometimes, additional imaging or laboratory tests are used to determine the tumor's activity and its effects on hormone production
Treatment Protocols: Treatment options vary depending on the size of the tumor, the hormones it secretes, and the presence of symptoms. Common approaches include: - Observation: Small, non-secreting tumors that do not cause symptoms may be monitored regularly - Medications: Drugs such as dopamine agonists for prolactin-secreting tumors, or somatostatin analogs for growth hormone-secreting tumors - Surgery: Transsphenoidal surgery is the most common method to remove the tumor, especially if it causes compressive symptoms or does not respond to medication - Radiation therapy: Used when surgery and medication are not effective or feasible, to reduce tumor size and control hormone secretion - Management of hormonal imbalances: Additional hormone therapy may be necessary to replace or block specific hormones affected by the tumor or its treatment
Clinical Advice & FAQs
Billing Guidance
Is D35.2 a billable ICD-10 code?
Yes, D35.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D35.2?
Clinical documentation must specify the nature of Benign neoplasm of pituitary gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference